Genentech DRC A MULTICENTER, RANDOMIZED, VISUAL ASSESSOR-MASKED, ACTIVE-COMPARATOR STUDY OF THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF THE PORT DELIVERY SYSTEM WITH RANIBIZUMAB IN PATIENTS WITH DIABETIC RETINOPATHY WITH OR WITHOUT DME
Research Grant
Awarded By
Genentech, Inc.
Start Date
July 4, 2020
End Date
April 30, 2028
Awarded By
Genentech, Inc.
Start Date
July 4, 2020
End Date
April 30, 2028